LAUREN PERUGINI: Open Payments
NPI 1366118069 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,141 in 201 payments from 17 companies in 2025. Trend: 2023 $3,715 · 2024 $3,103 · 2025 $4,141
Food & beverage: $4,080Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $613 |
| ABBVIE INC. | 33 | $553 |
| UCB, Inc. | 18 | $462 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $421 |
| PFIZER INC. | 17 | $332 |
| GENZYME CORPORATION | 12 | $280 |
| Regeneron Healthcare Solutions, Inc. | 8 | $274 |
| LEO Pharma Inc. | 15 | $265 |
| Arcutis Biotherapeutics, Inc. | 14 | $194 |
| Amgen Inc. | 8 | $162 |
Products named: TREMFYA, DUPIXENT, Bimzelx, CIBINQO, RINVOQ, SKYRIZI, Zoryve, Otezla.
Industry payments across CT — which companies pay providers there.
